[ad_1]
Industry experts say biotechs must prioritize validation, maturity, and alternative financing to overcome a lack of long-term funding.
[ad_2]
Funding lifelines: How to cross the 'valley of death'
Related Posts
Climactic launches hybrid fund to get startups through the ‘valley of death’
[ad_1] It’s a challenge every startup faces: they’ve made a prototype and proven the thing works, but now have to sell the product and produce […]
BYT Capital announces maiden fund focused on deeptech with Rs 180 corpus
[ad_1] Deeptech-focused venture capital firm BYT Capital has launched its maiden Rs 180 crore fund with more than half the corpus already subscribed. The Bengaluru-based […]
Mirakl turns profitable; recurring revenue, marketplace grow in 2025
[ad_1] Mirakl said it achieved full-year profitability in 2025, marking a financial milestone as recurring revenue and marketplace activity increased across its platform. The Boston- […]